NanoSomiX Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

NanoSomiX General Information

Description

Developer of brain analytic tools designed to detect neurological disorders. The company's tools utilize blood-based assay technology for further biomarker exploration in neurodegenerative diseases focusing on exosomes produced by various brain cell populations, enabling hospitals to get insights into neurological disorders via routine blood tests.

Contact Information

Website
www.nanosomix.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 27068 La Paz Road
  • Suite 555
  • Aliso Viejo, CA 92656
  • United States
+1 (949) 000-0000
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
TMT, HealthTech, Life Sciences
Corporate Office
  • 27068 La Paz Road
  • Suite 555
  • Aliso Viejo, CA 92656
  • United States
+1 (949) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NanoSomiX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 29-Apr-2022 Completed Generating Revenue
2. Early Stage VC Completed Startup
1. Angel (individual) Completed Startup
To view NanoSomiX’s complete valuation and funding history, request access »

NanoSomiX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of brain analytic tools designed to detect neurological disorders. The company's tools utilize blood-based ass
Biotechnology
Aliso Viejo, CA
00000000000

000 00

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labo
0000000000000
Birmingham, AL
00.000
00000000000 00.000

000000

ncididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostru
0000000000000
New York, NY
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NanoSomiX Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PNP Therapeutics Formerly VC-backed Birmingham, AL 00.000 00000000000 00.000
Brainstorm Cell Therapeutics Corporation New York, NY 00 000.00 000000000 000.00
Voyager Therapeutics Corporation Cambridge, MA 000 00000 00000000 00000
Intellia Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000 - 000 00000
Genespire Venture Capital-Backed Milan, Italy 00 000.00 00000000000 000.00
You’re viewing 5 of 17 competitors. Get the full list »

NanoSomiX Patents

  • 44

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 18

    Granted

  • 19

    Pending

  • 000

    Expiring in next 12 mo

NanoSomiX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4288775-A1 Methods, assays and compositions for measuring brain damage or harm during surgery Pending 03-Feb-2021 000000000
US-20240110930-A1 Methods, assays and compositions for measuring brain damage or harm during surgery Pending 03-Feb-2021 00000000000
JP-2024505653-A Methods, assays and compositions for measuring brain injury or injury during surgery Pending 03-Feb-2021 000000000
EP-3740567-A4 Detection of exosomes and exosomal biomarkers for the diagnosis and prognosis of diseases and disorders Inactive 18-Jan-2018 0000000000 0
EP-3740567-A1 Dectection of exosomes and exosomal biomarkers for the diagnosis and prognosis of diseases and disorders Inactive 18-Jan-2018 G01N33/543
To view NanoSomiX’s complete patent history, request access »

NanoSomiX Executive Team (5)

Name Title Board Seat
John Osth Chief Executive Officer and President
Amin Khalifa Co-Founder & Chief Financial Officer
Masato Mitsuhashi Ph.D Chief Technology Officer
Edward Goetzl MD Founder
Vicki Clements Vice President, Marketing
To view NanoSomiX’s complete executive team members history, request access »

Ready to get started?

Request a free trial

NanoSomiX FAQs

  • When was NanoSomiX founded?

    NanoSomiX was founded in 2014.

  • Who is the founder of NanoSomiX?

    Amin Khalifa and Edward Goetzl MD are the founders of NanoSomiX.

  • Who is the CEO of NanoSomiX?

    John Osth is the CEO of NanoSomiX.

  • Where is NanoSomiX headquartered?

    NanoSomiX is headquartered in Aliso Viejo, CA.

  • What industry is NanoSomiX in?

    NanoSomiX’s primary industry is Biotechnology.

  • Is NanoSomiX a private or public company?

    NanoSomiX is a Private company.

  • What is NanoSomiX’s current revenue?

    The current revenue for NanoSomiX is 00000.

  • Who are NanoSomiX’s competitors?

    PNP Therapeutics, Brainstorm Cell Therapeutics, Voyager Therapeutics, Intellia Therapeutics, and Genespire are some of the 17 competitors of NanoSomiX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »